Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
Top PubMed Articles
98 results
  • Chronic cholangitides: aetiology, diagnosis, and treatment. [Journal Article]
    Br Med J. 1968 Aug 31; 3(5617):515-21.Sherlock S
  • A number of different chronic diseases affect the intrahepatic bile radicles or cholangioles. They include primary and secondary sclerosing cholangitis, primary biliary cirrhosis, chronic cholestatic drug jaundice, atresia, and carcinoma. Aetiological factors include infection, immunological changes, hormones, and congenital defects.Patients with chronic cholestasis have decreased bile salts in t…
  • [Pharmacotherapeutics for the new coronavirus pneumonia]. [Review]
    Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12; 43(3):173-176.Du B, Qiu HB, … Tong ZH
  • The new coronavirus pneumonia (NCP), also named as COVID-19 by WHO on Feb 11 2020, is now causing a severe public health emergency in China since. The number of diagnosed cases is more than 40,000 until the submission of this manuscript. Coronavirus has caused several epidemic situations world widely, but the present contagious disease caused by 2019 new coronavirus is unprecedentedly fulminating…
  • Early prediction of twin-to-twin transfusion syndrome: systematic review and meta-analysis. [Review]
    Ultrasound Obstet Gynecol. 2017 May; 49(5):573-582.Stagnati V, Zanardini C, … Prefumo F
  • CONCLUSIONS: Monochorionic twin pregnancies with intertwin NT discrepancy, NT > 95th percentile, intertwin CRL discrepancy > 10% or abnormal DV flow on first-trimester ultrasound examination are at significantly increased risk of developing TTTS. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.
  • The fetuses-at-risk approach: survival analysis from a fetal perspective. [Review]
    Acta Obstet Gynecol Scand. 2018 Apr; 97(4):454-465.Joseph KS, Kramer MS
  • Several phenomena in contemporary perinatology create challenges for analyzing pregnancy outcomes. These include recent increases in iatrogenic delivery at late preterm and early term gestation, which are incongruent with the belief that stillbirth and neonatal death risks decrease exponentially with advancing gestational age. Perinatal epidemiologists have also puzzled over the paradox of inters…
  • Clinical Characteristics of Coronavirus Disease 2019 in China. [Journal Article]
    N Engl J Med. 2020 04 30; 382(18):1708-1720.Guan WJ, Ni ZY, … China Medical Treatment Expert Group for Covid-19
  • CONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.).
  • A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. [Randomized Controlled Trial]
    N Engl J Med. 2020 05 07; 382(19):1787-1799.Cao B, Wang Y, … Wang C
  • CONCLUSIONS: In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care. Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit. (Funded by Major Projects of National Science and Technology on New Drug Creation and Development and others; Chinese Clinical Trial Register number, ChiCTR2000029308.).
  • New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? [Journal Article]
    Int J Antimicrob Agents. 2020 May; 55(5):105938.Devaux CA, Rolain JM, … Raoult D
  • Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment measures, the spread of this virus is ongoing. SARS-CoV-2 is the aetiological agent of coronavirus disease 2019 (COVID-19) characterised by pulmonary infection in humans. The efforts of international health authorities have sinc…
  • [Pharmacotherapeutics for the New Coronavirus Pneumonia]. [Journal Article]
    Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 14; 43(0):E012.Du B, Qiu HB, … Tong ZH
  • The New Coronavirus Pneumonia (NCP, also named as COVID-19 by WHO on Feb 11 2020, is now causing a severe public health emergency in China since. The number of diagnosed cases is more than 40,000 until the submission of this manuscript. Coronavirus has caused several epidemic situations world widely, but the present contagious disease caused by 2019 new Coronavirus is unprecedentedly fulminating.…
  • Coronavirus disease 2019: What we know? [Review]
    J Med Virol. 2020 07; 92(7):719-725.He F, Deng Y, Li W
  • In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China. A few days later, the causative agent of this mysterious pneumonia was identified as a novel coronavirus. This causative virus has been temporarily named as severe acute respiratory syndrome coronavirus 2 and the relevant infected disease has been named as coronavirus disease 2019 (COVID-19) by the …
  • Discovering drugs to treat coronavirus disease 2019 (COVID-19). [Journal Article]
    Drug Discov Ther. 2020; 14(1):58-60.Dong L, Hu S, Gao J
  • The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19…
New Search Next